3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Smoldering Multiple Myeloma
1
Interventions
Lenalidomide
7
Dexamethasone
5
daratumumab
4
Calcium Dobesilate
4
dexamethasone acetate
3
dexamethasone 21-phosphate
3
auricularum
3
Curcumin
3
isatuximab
2
iberdomide
2
Leflunomide
2
pomalidomide
1
poly ICLC
1
piperine
1
pembrolizumab
1
ixazomib
1
fludarabine phosphate
1
fludarabine
1
citarinostat
1
Watchful Waiting
1
Urination
1
Stem Cell Transplantation
1
Resistance Training
1
Propranolol
1
Probiotics
1
Peripheral Blood Stem Cell Transplantation
1
PVX-410 vaccine
1
Observation
1
Metformin
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
IPH-2101
×
1 year
×
Clear all
NCT01222286
2026-05-14
KIRMONO
Innate Pharma
Phase 2
Completed
30 enrolled
10 charts